EUVIMEDAvasta EUVIMED
Open access · CC BY-NC-ND 4.0

Hyperfibrinolysis in Cats: A Retrospective Case–Control Study of 154 Cats

Anabel Priego-Corredor iD, María Rocío Del Saiz-Álvarez, Anna Vila-Soriano, Jorge Castro-López, Vicente Herrería-Bustillo

Journal of Veterinary Internal Medicine · 2025

DOI: 10.1111/jvim.70201 ↗

At a glance

Journal article in Journal of Veterinary Internal Medicine, 2025. Written by Anabel Priego-Corredor and 4 co-authors. Institution: Veterinary Teaching Hospital of the Catholic University of Valencia (VTHCUV), Valencia, Spain. Major MEDLINE topics: Cat Diseases, Fibrinolysis, Blood Coagulation Disorders. Cited 1 times so far (Crossref); 80 references. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstraktSubjectsBibliograafilised andmedCiteRelated studies

Abstract (original language)

Background

Hyperfibrinolysis (HFL) has not been well described in cats. Hypothesis/Objectives Identify risk factors associated with HFL in cats and evaluate its association with survival. Our hypotheses were that cats share similar conditions as dogs and humans with HFL and that it is associated with a worse prognosis. Animals A total of 154 client-owned cats had thromboelastography (TEG) performed because of a variety of clinical conditions.

Methods

Retrospective case–control study. Cases were defined as cats with HFL (clot lysis at 30 min [LY30] ≥ 5% or clot lysis at 60 min [LY60] ≥ 10% or both) and controls were cats that had TEG performed but without HFL. Signalment, conditions that may alter fibrinolysis, TEG variables, indications to perform TEG, and outcome were recorded.

Results

Fifty-two cats (33.8%) with HFL and 102 controls (66.2%) were included. Demographic variables were similar between groups. Both liver disease (odds ratio [OR], 5.0; 95% confidence interval [CI], 2.4–10.6; p < 0.001) and the presence of cavitary effusion (OR, 5.9; 95% CI, 2.8–12.4; p < 0.001) were important risk factors for HFL. Cats with heart disease were less likely to have HFL (OR, 0.2; 95% CI, 0.1–0.5; p < 0.001). The presence of HFL was not associated with worse outcome (p = 0.84). Cats with HFL more often were hypocoagulable, whereas cats without HFL more often were hypercoagulable (p < 0.001). Conclusions and Clinical Importance Liver disease and cavitary effusion are risk factors for HFL in cats. The presence of HFL did not affect survival.

Subjects

MeSH terms (MEDLINE)

Cat DiseasesFibrinolysisBlood Coagulation DisordersAnimalsCatsRetrospective StudiesCase-Control StudiesFemaleMaleThrombelastographyRisk Factors

Author keywords

cavitary effusioncoagulationfibrinolysisheart diseaseliver diseasethromboelastography

Authors and institutions

  • Veterinary Teaching Hospital of the Catholic University of Valencia (VTHCUV), Valencia, Spain.
  • AniCura Valencia Sur Veterinary Hospital, Internal Medicine, Silla, Spain.

ORCID profiles: Anabel Priego-Corredor

Cite

APA

Priego-Corredor, A., Del Saiz-Álvarez, M. R., Vila-Soriano, A., Castro-López, J., & Herrería-Bustillo, V. (2025). Hyperfibrinolysis in Cats: A Retrospective Case–Control Study of 154 Cats. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.70201

Vancouver

Priego-Corredor A, Del Saiz-Álvarez MR, Vila-Soriano A, Castro-López J, Herrería-Bustillo V. Hyperfibrinolysis in Cats: A Retrospective Case–Control Study of 154 Cats. Journal of Veterinary Internal Medicine. 2025. doi:10.1111/jvim.70201

BibTeX
@article{PriegoCorredor2025,
  author = {Priego-Corredor, Anabel and Del Saiz-Álvarez, María Rocío and Vila-Soriano, Anna and Castro-López, Jorge and Herrería-Bustillo, Vicente},
  title = {Hyperfibrinolysis in Cats: A Retrospective Case–Control Study of 154 Cats},
  journal = {Journal of Veterinary Internal Medicine},
  year = {2025},
  doi = {10.1111/jvim.70201}
}
Start for free →